Sette Alessandro, Moutaftsi Magdalini, Moyron-Quiroz Juan, McCausland Megan M, Davies D Huw, Johnston Robert J, Peters Bjoern, Rafii-El-Idrissi Benhnia Mohammed, Hoffmann Julia, Su Hua-Poo, Singh Kavita, Garboczi David N, Head Steven, Grey Howard, Felgner Philip L, Crotty Shane
Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI), La Jolla, CA 92037, USA.
Immunity. 2008 Jun;28(6):847-58. doi: 10.1016/j.immuni.2008.04.018.
Antibody responses are critical components of protective immune responses to many pathogens, but parameters determining which proteins are targeted remain unclear. Vaccination with individual MHC-II-restricted vaccinia virus (VACV, smallpox vaccine) epitopes revealed that CD4(+) T cell help to B cells was surprisingly nontransferable to other virion protein specificities. Many VACV CD4(+) T cell responses identified in an unbiased screen targeted antibody virion protein targets, consistent with deterministic linkage between specificities. We tested the deterministic linkage model by efficiently predicting new vaccinia MHC II epitopes (830% improved efficiency). Finally, we showed CD4(+) T cell help was limiting for neutralizing antibody development and protective immunity in vivo. In contrast to the standard model, these data indicate individual proteins are the unit of B cell-T cell recognition for a large virus. Therefore, MHC restriction is a key selective event for the antiviral antibody response and is probably important for vaccine development to large pathogens.
抗体反应是针对许多病原体的保护性免疫反应的关键组成部分,但决定哪些蛋白质成为靶点的参数仍不清楚。用单个MHC-II限制性痘苗病毒(VACV,天花疫苗)表位进行疫苗接种表明,CD4(+) T细胞对B细胞的辅助作用出人意料地无法转移到其他病毒粒子蛋白特异性上。在一项无偏差筛选中鉴定出的许多VACV CD4(+) T细胞反应靶向抗体病毒粒子蛋白靶点,这与特异性之间的确定性联系一致。我们通过有效预测新的痘苗MHC II表位(效率提高了830%)来测试确定性联系模型。最后,我们表明CD4(+) T细胞辅助作用在体内对中和抗体的产生和保护性免疫具有限制作用。与标准模型相反,这些数据表明单个蛋白质是大型病毒的B细胞-T细胞识别单位。因此,MHC限制是抗病毒抗体反应的关键选择性事件,可能对大型病原体疫苗的开发很重要。